10864181

6 known cases. View patent page →

Cases
6
Active
2
4 closed
Filed
2020–2023
Top venue
D. New Jersey
4 cases

Filing activity

2020: 1 case1'202021: 1 case'212022: 1 case'222023: 1 case'23
Cases asserting US Patent 10864181 filed per year.

In re Xyrem (Sodium Oxybate) Antitrust Litigation

Docket:
3:20-md-02966
Court:
N.D. Cal.
Filed:
2020-12-16

MDL antitrust litigation in N.D. Cal. in which US 6,780,889 is listed among the patents at issue, along with US 10,213,400, US 10,864,181, and US 7,262,219, among others. The claims are antitrust, not patent infringement.

Jazz Pharmaceuticals Ireland Ltd. v. Tris Pharma, Inc.

pending; motion to dismiss denied
Docket:
2:26-cv-01739
Patents:10864181

Jazz Pharmaceuticals Ireland Ltd. sued Tris Pharma, Inc. in the District of New Jersey. Judge Stanley R. Chesler denied Tris's motion to dismiss on July 8, 2026, and an answer, counterclaim, and scheduling order followed.

Avadel CNS Pharmaceuticals, LLC v. Jazz Pharmaceuticals, Inc.

settled
Docket:
1:22-cv-00487
Filed:
2022-04-14
Terminated:
2025-10-27
Patents:10864181

Avadel CNS Pharmaceuticals, LLC filed a case against Jazz Pharmaceuticals, Inc. in the District of Delaware. It was part of the global Jazz-Avadel dispute and was settled in October 2025, with District of Delaware cases terminated 2025-10-27.